IRIS
BONI, CAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.286
AS - Asia 1.984
EU - Europa 1.364
SA - Sud America 366
AF - Africa 121
OC - Oceania 7
Totale 6.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.208
SG - Singapore 834
CN - Cina 553
IT - Italia 387
BR - Brasile 304
IE - Irlanda 235
HK - Hong Kong 191
DE - Germania 175
SE - Svezia 168
VN - Vietnam 131
TR - Turchia 79
NL - Olanda 76
ZA - Sudafrica 76
FI - Finlandia 74
FR - Francia 68
CA - Canada 51
RU - Federazione Russa 42
IN - India 38
AR - Argentina 28
GB - Regno Unito 27
BD - Bangladesh 24
KR - Corea 24
MX - Messico 21
JP - Giappone 19
CI - Costa d'Avorio 18
AT - Austria 15
BE - Belgio 13
IQ - Iraq 13
ID - Indonesia 12
PK - Pakistan 12
UA - Ucraina 11
DK - Danimarca 10
LT - Lituania 10
EC - Ecuador 8
PL - Polonia 8
UZ - Uzbekistan 8
CO - Colombia 7
ES - Italia 7
MA - Marocco 7
PY - Paraguay 7
AU - Australia 6
CZ - Repubblica Ceca 6
CH - Svizzera 5
IR - Iran 5
KE - Kenya 5
RO - Romania 5
SA - Arabia Saudita 5
TW - Taiwan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BO - Bolivia 3
EG - Egitto 3
IL - Israele 3
LV - Lettonia 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
TN - Tunisia 3
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
LU - Lussemburgo 2
OM - Oman 2
PA - Panama 2
TZ - Tanzania 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TG - Togo 1
TO - Tonga 1
Totale 6.128
Salva come PNG Salva come JPEG
Città #
Dallas 412
Singapore 406
Ashburn 283
Santa Clara 257
Dublin 234
Hong Kong 189
Chandler 177
Parma 138
Beijing 135
Boardman 93
New York 88
Munich 85
Dearborn 79
Johannesburg 70
Shanghai 68
Izmir 65
Los Angeles 60
Ann Arbor 55
Ho Chi Minh City 47
Milan 45
Hanoi 39
Hefei 34
Nanjing 34
Princeton 34
São Paulo 32
Wilmington 31
Turku 28
Buffalo 26
Columbus 25
Moscow 23
Chicago 22
Toronto 21
Bologna 20
Frankfurt am Main 19
Abidjan 18
Shenyang 18
Rio de Janeiro 17
Tokyo 17
Houston 16
Nuremberg 16
Seoul 15
Grafing 14
Helsinki 14
Montreal 14
Nanchang 14
Brussels 13
Guangzhou 13
Hebei 13
Seattle 12
The Dalles 12
Bremen 11
Changsha 11
Phoenix 11
Denver 10
Düsseldorf 10
Jacksonville 10
Reggio Emilia 10
Bengaluru 9
Brooklyn 9
Jakarta 9
Limena 9
Orem 9
Rome 9
San Francisco 9
Vienna 9
Baghdad 8
Curitiba 8
London 8
Montespertoli 8
Taastrup 8
Tianjin 8
Zhengzhou 8
Council Bluffs 7
Hangzhou 7
Jinan 7
Ottawa 7
Tashkent 7
Warsaw 7
Chennai 6
Mexico City 6
Norwalk 6
Rockville 6
Atlanta 5
Boston 5
Brasília 5
Da Nang 5
Focsani 5
Indianapolis 5
Istanbul 5
Jiaxing 5
Kunming 5
San Jose 5
Ardea 4
Baku 4
Bangkok 4
Belo Horizonte 4
Bolzano 4
Bordeaux 4
Campinas 4
Charlotte 4
Totale 3.959
Salva come PNG Salva come JPEG
Nome #
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 255
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 236
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 227
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 201
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 165
Therapeutic potential of co-signaling receptor modulation in hepatitis B 148
Metabolic regulation of the HBV-specific T cell function 146
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 136
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 132
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 128
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 128
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 127
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 124
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 124
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 122
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 122
HBV immune-therapy: From molecular mechanisms to clinical applications 119
T cell regulation in HBV-related chronic liver disease 118
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 117
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 114
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 112
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 108
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 105
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 102
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 101
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 97
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 97
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 93
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 92
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 92
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 91
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 89
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 89
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 87
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 87
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 84
Comparative pathogenesis of HBV and HCV 83
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 83
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 83
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 82
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 82
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 78
Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B 78
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 78
Effector CD8(+) T cell-derived interleukin-10 enhances acute liver immunopathology 77
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy 76
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 74
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 73
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers 71
The scientific basis of combination therapy for chronic hepatitis B functional cure 70
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma 68
Immunopathogenesis of hepatitis C virus infection 67
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B 67
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections 67
Hepatitis B virus specific immune response: From antigen recognition to liver damage 63
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma 63
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor 57
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire 51
T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection 50
HBV antigens quantity: duration and effect on functional cure 50
Immunopathogenesis of hepatitis B 41
Totale 6.247
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 15 20 13 29 15 9 15
2021/2022198 8 4 3 26 20 21 11 13 13 4 11 64
2022/2023771 82 66 42 49 58 78 15 40 258 6 40 37
2023/2024548 27 49 27 52 31 119 56 28 25 35 37 62
2024/20251.912 63 91 102 127 200 234 110 127 232 136 163 327
2025/20262.164 348 568 390 296 470 92 0 0 0 0 0 0
Totale 6.247